Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Research Synthesis Methods
|
June 9, 2015
Unsolved issues of mixed treatment comparison meta-analysis: network size and inconsistency
Sibylle Sturtz, Ralf Bender
Biometrical Journal. Biometrische Zeitschrift
|
October 17, 2013
Comparison of Bayesian methods for flexible modeling of spatial risk surfaces in disease mapping
Sibylle Sturtz, Katja Ickstadt
Geospatial Health
|
August 8, 2008
A descriptive and model-based spatial comparison of the standardised mortality ratio and the age-standardised mortality rate
Sibylle Sturtz, Katja Ickstadt
BMC Medical Research Methodology
|
February 26, 2020
A simulation study to compare different estimation approaches for network meta-analysis and corresponding methods to evaluate the consistency assumption
Corinna Kiefer, Sibylle Sturtz, Ralf Bender
Deutsches Arzteblatt International
|
December 5, 2015
Indirect Comparisons and Network Meta-Analyses
Corinna Kiefer, Sibylle Sturtz, Ralf Bender
Journal of Clinical Epidemiology
|
June 25, 2013
Absolute risks rather than incidence rates should be used to estimate the number needed to treat from time-to-event data
Ralf Bender, Mandy Kromp, Corinna Kiefer, et al.
Journal of Clinical Epidemiology
|
November 5, 2013
Estimation of numbers needed to treat should be based on absolute risks
Ralf Bender, Mandy Kromp, Corinna Kiefer, et al.
Statistics in Medicine
|
April 2, 2023
Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis
Christian Röver, Sibylle Sturtz, Jona Lilienthal, et al.
Plos One
|
August 11, 2016
Assumptions of Mixed Treatment Comparisons in Health Technology Assessments - Challenges and Possible Steps for Practical Application
Stefanie Reken, Sibylle Sturtz, Corinna Kiefer, et al.
Journal of Clinical Epidemiology
|
November 15, 2017
Trial registry searches for randomized controlled trials of new drugs required registry-specific adaptation to achieve adequate sensitivity
Marco Knelangen, Elke Hausner, Maria-Inti Metzendorf, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Research Synthesis Methods
|
June 9, 2015
Unsolved issues of mixed treatment comparison meta-analysis: network size and inconsistency
Sibylle Sturtz, Ralf Bender
Biometrical Journal. Biometrische Zeitschrift
|
October 17, 2013
Comparison of Bayesian methods for flexible modeling of spatial risk surfaces in disease mapping
Sibylle Sturtz, Katja Ickstadt
Geospatial Health
|
August 8, 2008
A descriptive and model-based spatial comparison of the standardised mortality ratio and the age-standardised mortality rate
Sibylle Sturtz, Katja Ickstadt
BMC Medical Research Methodology
|
February 26, 2020
A simulation study to compare different estimation approaches for network meta-analysis and corresponding methods to evaluate the consistency assumption
Corinna Kiefer, Sibylle Sturtz, Ralf Bender
Deutsches Arzteblatt International
|
December 5, 2015
Indirect Comparisons and Network Meta-Analyses
Corinna Kiefer, Sibylle Sturtz, Ralf Bender
Journal of Clinical Epidemiology
|
June 25, 2013
Absolute risks rather than incidence rates should be used to estimate the number needed to treat from time-to-event data
Ralf Bender, Mandy Kromp, Corinna Kiefer, et al.
Journal of Clinical Epidemiology
|
November 5, 2013
Estimation of numbers needed to treat should be based on absolute risks
Ralf Bender, Mandy Kromp, Corinna Kiefer, et al.
Statistics in Medicine
|
April 2, 2023
Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis
Christian Röver, Sibylle Sturtz, Jona Lilienthal, et al.
Plos One
|
August 11, 2016
Assumptions of Mixed Treatment Comparisons in Health Technology Assessments - Challenges and Possible Steps for Practical Application
Stefanie Reken, Sibylle Sturtz, Corinna Kiefer, et al.
Journal of Clinical Epidemiology
|
November 15, 2017
Trial registry searches for randomized controlled trials of new drugs required registry-specific adaptation to achieve adequate sensitivity
Marco Knelangen, Elke Hausner, Maria-Inti Metzendorf, et al.
Page
of 2